↓ Skip to main content

MAP17 predicts sensitivity to platinum-based therapy, EGFR inhibitors and the proteasome inhibitor bortezomib in lung adenocarcinoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
2 X users
googleplus
1 Google+ user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
19 Mendeley